TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03040323

Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses

Cause of deathSlow enrollment, also staffing, sites or logistics Automatic label, confidence 0.6, unverified. How labels are made.
“Insufficient patient recruitment. Data lost following departure of key personnel”

The sponsor’s own words in the registry.

Life of this trial

20162017201820192020Started2016-12-22Registered2017-01-31Primary completion2018-06-30Stopped2018-07-06Results posted2019-07-24

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
Indiana University
Sponsor type
University, hospital or other
Conditions
Liver Biopsy
Interventions
Lumason 60.7Mg Powder for Injection; Placebos
Participants
83
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.